BioTechnology
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
By Business Wire
Share
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its full year 2022 financial results on Tuesday, February 21, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
Contacts
Inquiries
Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Josephine Hellschlienger Ph.D.; ir@abcellera.com, +1(778)729-9116
Liked what you read? Head to the TechDogs homepage to find the latest tech content infused with drama and entertainment. We've got Articles, White Papers, Case Studies, Reports, Videos, TechNews and Events - the complete lot to help you Know Your World of Technology.
First published on Wed, Jan 25, 2023
Enjoyed what you've read so far? Great news - there's more to explore!
Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.
Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.
Dive into TechDogs' treasure trove today and Know Your World of technology!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs' site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.
Tags:
Related News on BioTechnology
Evonetix Closes $24 Million USD (20 Million) Financing
Tue, Feb 7, 2023
By Business Wire
Kane Biotech Strengthens Board With Biotech Executive
Fri, Nov 17, 2023
By GlobeNewswire
Trinity Life Sciences And WhizAI Announce Partnership
Wed, Apr 26, 2023
By Business Wire
Kiromic BioPharma Announces Uplisting To OTCQB Market
Fri, Nov 17, 2023
By Business Wire
Trending Business Wire
Halan And Truecaller Collaborate To Redefine Communication Safety In Egypts Fintech Landscape
By Business Wire
Houston Area School District Is First In Texas To Add Powerschool AI Assistant Powerbuddy To Classrooms
By Business Wire
KAYTUS Unveils Next-Generation Air-Cooled Containerized AI Computing
By Business Wire
Mahindra & Mahindra Selects Kinaxis To Drive Supply Chain Efficiencies For Growing Automotive Portfolio
By Business Wire
Neo Financial Ranks No. 1 On The Globe And Mails 2024 List Of Canadas Top Growing Companies
By Business Wire
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion